CUSIP: 286221106
What is CUSIP 286221106?
CUSIP 286221106 identifies EBIO - ELEVEN BIOTHERAPEUTICS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 286221106:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2021 Q1 | 0 | $0 | -$6,536,000 | 0 | |
| 2020 Q4 | 4,841,591 | $6,536,000 | $1.35 | 1 | |
| 2020 Q3 | 4,841,591 | $6,778,000 | $1.40 | 1 | |
| 2020 Q2 | 4,841,591 | $3,486,000 | $0.72 | 1 | |
| 2020 Q1 | 4,841,591 | $2,716,000 | $0.56 | 1 | |
| 2019 Q4 | 4,841,591 | $5,035,000 | $1.04 | 1 | |
| 2019 Q3 | 4,841,591 | $5,665,000 | $1.17 | 1 | |
| 2019 Q2 | 4,841,591 | $7,262,000 | $1.50 | 1 | |
| 2019 Q1 | 4,841,591 | $4,987,000 | $1.03 | 1 | |
| 2018 Q4 | 4,841,591 | $6,875,000 | $1.42 | 1 | |
| 2018 Q3 | 4,841,591 | $10,409,000 | $2.15 | 1 | |
| 2018 Q2 | 4,841,591 | $9,441,000 | -$5,864,000 | $1.95 | 1 |
| 2018 Q1 | 10,427,407 | $5,869,084 | +$4,069,615 | $1.05 | 24 |
| 2017 Q4 | 6,643,558 | $5,383,000 | +$429,387 | $0.81 | 18 |
| 2017 Q3 | 1,218,710 | $1,926,000 | +$142,016 | $1.58 | 17 |
| 2017 Q2 | 1,241,792 | $1,947,000 | +$167,121 | $1.57 | 20 |
| 2017 Q1 | 2,393,349 | $5,262,000 | +$807,687 | $2.20 | 26 |
| 2016 Q4 | 2,525,054 | $4,821,000 | -$3,867,522 | $1.91 | 25 |
| 2016 Q3 | 4,120,415 | $11,537,000 | +$643,151 | $2.80 | 24 |
| 2016 Q2 | 3,506,535 | $5,874,000 | +$1,312,714 | $1.67 | 20 |
| 2016 Q1 | 5,225,587 | $1,669,000 | -$20,789,967 | $0.32 | 18 |
| 2015 Q4 | 9,718,450 | $29,250,000 | +$1,041,157 | $3.01 | 25 |
| 2015 Q3 | 14,234,741 | $34,304,000 | -$364,289 | $2.41 | 25 |
| 2015 Q2 | 14,190,910 | $40,017,705 | -$16,862,515 | $2.82 | 39 |
| 2015 Q1 | 13,350,820 | $119,091,408 | -$3,234,662 | $8.92 | 48 |
| 2014 Q4 | 13,481,626 | $159,436,208 | +$20,513,994 | $11.88 | 41 |
| 2014 Q3 | 11,695,222 | $130,326,363 | -$38,170 | $11.14 | 41 |
| 2014 Q2 | 11,595,794 | $152,829,525 | +$3,048,003 | $13.18 | 37 |
| 2014 Q1 | 11,407,863 | $185,148,000 | +$185,148,000 | $16.23 | 32 |